500 patients67,039 observations150 daysLIVE

Patient P-03308

Synthetic patientONX-7 · Day 104 · 45–54 · M · baseline S04Steering view · 3DOpen companion preview
Therapy response
Unstable
Tolerance
Favorable
GI state
Favorable
Inflammatory state
Improving
Nutritional resilience
Improving
Discontinuation risk
10%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 ONX-7 startedBaseline state S04
  2. Day 90 BR-03 recommendedBehavioural Recommendation BR-03
  3. Day 91 Patient acceptedStarted BR-03 in the companion
  4. Day 98 Trajectory diverged from predictionObserved response fell below the model's expected path.
  5. Day 98 GI symptom burden −14% vs expectedBehavioural Recommendation BR-03
  6. Day 104 Tolerance state changedUnstable → Improving

What changed?

Trajectory began diverging from predicted response on Day 98.

Primary contributors, last 14 days
  • Treatment adherence+6
  • Inflammatory activity-5
  • Nutritional resilience+5
  • GI instability-3

What helped?

  • Behavioural Recommendation BR-03Day 90
    Result: symptom burden −14%
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Energy level
Daily log
6.3/10
worsening · -0.6 vs previous 14 d
Stress level
Daily log
3/10
stable · -0.1 vs previous 14 d
Pessimism score
Daily log
4.1/10
worsening · +0.3 vs previous 14 d
Sleep quality
Wearable
60.8/100
worsening · -2.7 vs previous 14 d
Libido
Daily log
5.8/10
stable · +0.0 vs previous 14 d
HRV
Wearable
60.7 ms
stable · -0.6 vs previous 14 d
Toxicity
Blood
13.5/100
worsening · +3.1 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →

Heading towards failing · 74 from the failing basin, 40 from restoration.

Would help
  • No untried action with strong evidence. Compose one from primitives.
  • More protein
    GI -3.8 next day on high-intake days · n 21
Would not help
  • AD-05 Adherence Support
    only 31% improved among 16 similar
  • Keep alcohol low
    GI +3 next day on high-intake days · n 18
  • Keep lactose low
    GI +2.3 next day on high-intake days · n 16
State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

  • Protein
    -3.8supporter · 95%
  • Alcohol
    +3detractor · 95%
  • Lactose
    +2.3detractor · 65%
  • Caffeine
    +1no signal · 29%
  • Histamine load
    -0.9no signal · 28%
  • Dietary fat load
    +0.3no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure
  • Inflammatory signalling 20
    • MicrobiomeBacteroides fragilis expansion
DNA
Fictional pharmacogenomic panel
  • CYP2D6 Normal metabolizer
    Expected exposure
  • MTHFR C677T
    Reduced folate turnover
Microbiome
Shannon diversity 4.5 · butyrate capacity 73/100
  • Akkermansia muciniphilaNormal
  • Faecalibacterium prausnitziiNormal
  • Bacteroides fragilisHigh
  • Bifidobacterium longumLow
  • EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
HRV
59 ms
Sleep
6.9 h
Steps
9,938
Resting HR
56 bpm
Daily log: GI score 18, nutritional resilience 66, adherence 97.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview
What to eat
  • Keep meals regular; three to four moderate portions spaced through the day
  • Include a cooked vegetable portion with each main meal
  • Keep fibre steady; no new sources this week
  • Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
  • Log the daily check-in; one line is enough
  • Keep the current walking rhythm
  • Keep the sleep window steady
  • Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
  • Take the scheduled dose as agreed with your care team
  • No additional supplements this week
  • Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

PatientSimilarityBaselineInterventionOutcomeResponse today
P-0344145%S19AD-05improved37
P-0312939%S18AD-05no change32
P-0338038%S16AD-05improved34
P-0312237%S13AD-05no change40
P-0320436%S16AD-05improved48
P-0335136%S07AD-05no change51
P-0336936%S18AD-05no change37
P-0342436%S12AD-05improved41
P-0303434%S14AD-05no change30
P-0310533%S12AD-05no change60
P-0315832%S17AD-05no change37
P-0311130%S07AD-05no change48